Comparison of benefit between dabigatran and warfarin among patients with atrial fibrillation: A systematic review
Warfarin is recognized as the standard antithrombotic agent for stroke prevention. However, new oral anticoagulant such as dabigatran constitutes huge improvement to compensate for the limitation of warfarin. A literature review was performed to compare and contrast the overall benefit of dabigatran...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Archives of Global Professionals,
2016-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|